Astellas Seeks Conditional Approval in Japan for Geographic Atrophy Treatment Without Japanese Patient Data

ELIQUENT Japan > Pharma Innovation

2025.02.27

White,pills,from,plastic,medicine,bottle,on,blue,background,with

Astellas Seeks Conditional Approval in Japan for Geographic Atrophy Treatment Without Japanese Patient Data

Introduction to Astellas’ Pioneering Regulatory Submission According to the news (News | Astellas Pharma Inc.) […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
 Phone:+81-3-6304-5570